Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Maternity
  4. Back
  5. Pregnancy losses
  6. Fetal Tissue - handling and disposal (up to and including 23+6 weeks gestation) (340)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Fetal Tissue - handling and disposal (up to and including 23+6 weeks gestation) (340)

Warning

Objectives

This document provides guidance on the handling and disposal of tissue which contains, or potentially contains, fetal tissue of up to and including 23+6 weeks gestation.

Scope

All pregnancy tissue up to and including 23+6 weeks gestation

Audience

This guideline is intended for use by healthcare professionals working within GGC.  In particular this is relevant to Pathology Department Medical and BMS Staff, Mortuary MTO Staff Obstetrics and Gynaecology, Medical, Nursing, Midwifery and theatre staff in Obstetrics and Gynaecology, Medical and Nursing Staff working in Accident and Emergency.

Please report any inaccuracies or issues with this guideline using our online form

NHS GG&C Policy on the Handling and Disposal of Fetal Tissue (up to and including 23+6 weeks gestation) 

This document is to provide guidance on the handling and disposal of tissue which contains, or potentially contains, fetal tissue of up to and including 23+6 weeks gestation. 

This includes:

  • Medical Termination of Pregnancy tissue
  • Surgical Termination of Pregnancy tissue
  • Ectopic Pregnancy tissue
  • Any tissue from an Early Pregnancy Loss (including spontaneous loss, medically managed, surgically managed and MVA)
  • Fetuses of up to and including 23+6 weeks gestation where there has been a Post Mortem Examination
  • Retained products of conception specimens

Our aim is to ensure that all fetal tissue is handled appropriately and disposed of respectfully. This has been defined as Shared Cremation with agreement of the Department of Obstetrics and Gynaecology. The purpose of this document is to provide guidance and clarity as to the appropriate examination of tissue and the paperwork which is required to allow this examination and disposal. 

Medical Termination of Pregnancy

The majority of these specimens do not require histopathological assessment. If no histopathological examination is required then the tissue should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed copy of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2).

If the tissue is to be released directly to the family then a release of pregnancy tissue form should be completed by clinical staff. If the patient opts to take the specimen from the Pathology Department then the relevant section of Form 2 should be completed and submitted with the specimen. In addition, a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

If there are concerns about fetal anomalies and examination is required then appropriate Post Mortem Consent should be obtained.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sampled and processed to FFPE blocks and stored in the pathology archives. No glass slides or formal histopathology report will be prepared until a completed copy of Form 2 is received by the pathology department. Following receipt of a completed copy of Form 2, a replacement request form will be required in order to generate a report on Trak Care. The remainder of the specimen will be sensitively disposed of without further examination.

NB: If a molar pregnancy is suspected clinically, accurate details of the clinical team treating the patient must be included with the request form so that if an error is identified in Form 2, the clinical team can be contacted regarding the non-conformance in a timely manner.

A Datix will be raised by Pathology if an error is made in a Form 2 that is not rectified within 4 weeks of submitting the specimen. If a Form 2 is being resubmitted, then a replacement pathology request must be made via Trak Care to generate a pathology report on Trak Care.

Surgical Termination of Pregnancy

These specimens do not require histopathological assessment. They should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed copy of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). If the patient opts to take the specimen from the Pathology Department then the appropriate section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and submitted with the specimen. In addition, a completed PATHCOM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sensitively disposed of without further examination.

Ectopic Pregnancy Tissue

These specimens should be sent for histopathological examination for confirmation of ectopic pregnancy and assessment of associated pathology. These specimens should be submitted to the Pathology Department with a Pathology Request form (containing relevant clinical information) and with a completed Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). Following reporting, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). If the patient opts to take the specimen from the Pathology Department then the appropriate section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and submitted with the specimen. In addition, a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will placed into FFPE blocks and processed for histology. The FFPE blocks to confirm the presence of an ectopic pregnancy will remain in the pathology archives and a histopathology report will be generated when a completed copy of Form 2 is received. If this is required, a replacement specimen request form will be required to generate a report on Trak Care.

Early Pregnancy Loss Tissue

This includes spontaneously passed tissue and surgically removed tissue. It is for the sender to decide whether histopathological examination is desirable.

Possible reasons for examination include

  • Confirmation of products of conception
  • Exclusion of gestational trophoblastic disease
  • Attempts at determining cause of recurrent miscarriage

If histopathological examination is required, then the specimen should be submitted to the Pathology Department with a Pathology Request form (containing relevant clinical information) and a completed Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). Following reporting, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). If the patient opts to take the specimen from the Pathology Department then the relevant section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

If no histopathological examination is required and the patient opts for the hospital to sensitively dispose of the specimen, then the specimen should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed Form 2. If no histopathological examination irequired and the patient opts to take the tissue from the hospital the relevant section of Form 2 should also be completed to provide an audit trail for the fetal tissue as well as a completed release of pregnancy tissue form. The tissue can be passed to the patient in a suitable container. The paperwork (Form 2) should be sent to the Mortuary for registration.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sampled to FFPE block but no glass slide or formal histopathology report will be available until a completed Form 2 is received. The remainder of the specimen will be sensitively disposed of without further examination. If a histopathology report is required following receipt of the completed form 2, then a replacement pathology request will be required to generate a report on Trak Care.

NB: If a molar pregnancy is suspected clinically, accurate details of the clinical team treating the patient must be included with the request form so that if an error is identified in Form 2, the clinical team can be contacted regarding the non-conformance in a timely manner. A Datix will be raised by Pathology if an error is made in a Form 2 that is not rectified within 4 weeks of submitting the specimen. If a Form 2 is being resubmitted, then a replacement pathology request must be made via Trak Care to generate a pathology report on Trak Care.

Recurrent Miscarriage or Suspected Underlying Cytogenetic Cause of Pregnancy Loss

RCOG Guidelines (GT17) recommend that cytogenetic analysis of the products of conception should be performed for all couples with a history of recurrent miscarriage, (loss of three or more pregnancies).

Previously this required division of tissue for both histological and cytogenetic analysis. With the centralization of laboratory services this is no longer necessary. Products of conception should be sent complete to Cytogenetics (in a dry sterile container – not in formalin) with the relevant request form giving a clear history and a completed Form 2. Please ensure that the sample container itself is also labelled with appropriate patient identifiers. Following examination within both Cytogenetics and Pathology, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). The same applies to the examination of fetal and placental tissues where an underlying cytogenetic cause is suspected e.g. following detection of abnormality on early ultrasound scan or miscarriage associated with raised risk of aneuploidy on antenatal screening.

Fetuses up to and including 23+6 weeks gestation where there is to be a Post Mortem Examination

These specimens should be transferred directly to the mortuary along with any associated placental tissue and appropriately completed Post Mortem Consent Forms. The further handling of these requests is detailed elsewhere.

Retained Products of Conception Specimens in which there has been a separately identified fetus

This clinical scenario has been previously discussed at the Sensitive Disposal Committee. It has been agreed that there is no requirement to supply a Form 2. Surplus tissue will be disposed of as clinical waste.

Tissue Type

Tissue Flow

Sample and Paperwork Required

Medical Termination of Pregnancy tissue

Histopathology assessment not required and tissue for shared cremation/sensitive disposal

  • pathology/tissue specimen dry specimen -completed Form 2

Send to the mortuary, QEUH

Medical Termination of Pregnancy tissue

If specimen does not require Histopathology assessment and being released to family without further assessment

  • pathology/tissue specimen dry
  • completed Form 2 – send to pathology for registration -release of pregnancy tissue form
  • Tissue to be sent with parent

Medical Termination of Pregnancy tissue

If specimen requires histopathology assessment

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to the pathology department, QEUH *

Medical Termination of Pregnancy tissue

If specimen requires cytogenetic and histopathology assessment

  • pathology/tissue specimen in sterile dry pot
  • completed Form 2
  • pathology request form
  • cytogenetics request form

Send to the Cytogenetics department, QEUH*

Medical Termination of Pregnancy tissue

If specimen requires postmortem assessment

  • pathology/tissue/fetal specimen
  • completed Form 2
  • pathology request form (for placenta)
  • completed PM authorisation form

Send fetus and placenta as dry sample to mortuary

Send to the pathology department, QEUH*

Surgical Termination of Pregnancy tissue

Histopathology assessment not required

  • pathology/tissue specimen dry specimen -completed Form 2

Send to the mortuary, QEUH*

Surgical Termination of Pregnancy tissue

If specimen requires histopathology assessment

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to the pathology department, QEUH*

If suspected molar pregnancy please ensure clear documentation of lead clinician and contact details

Surgical Termination of Pregnancy tissue

If specimen requires cytogenetic and histopathology assessment

  • pathology/tissue specimen in dry sterile pot
  • completed Form 2
  • pathology request form
  • cytogenetic request form

Send to the Cytogenetics department, QEUH*

Ectopic Pregnancy tissue

Histopathology required

  • pathology specimen in formalin
  • completed Form 2
  • pathology request form

Send to Pathology Department, QEUH*

Tissue from an Early Pregnancy Loss (pregnancy loss up to 11+6 weeks gestation)

Histopathology required

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to Pathology Department, QEUH *

Tissue from an Early Pregnancy Loss (pregnancy loss up to 11+6 weeks gestation)

Histopathology NOT required

  • pathology specimen (dry ) -completed Form 2

Send to the Mortuary, QEUH

Tissue after recurrent miscarriage (3 consecutive early losses)

Tissue for histopathology and cytogenetics

  • pathology specimen in dry sterile container -pathology request
  • cytogenetics request -completed Form 2

Send to Cytogenetics department QEUH*

Fetus of between 11 and 23+6 weeks gestation where there is a Post Mortem Examination (postmortem requests for less than 11 weeks gestation MUST be discussed with a pathologist)

Histopathology and Post

Mortem Examination required

  • pathology/tissue/fetal specimen
  • completed Form 2
  • pathology request form (for placenta)
  • completed PM authorisation form

Send fetus and placenta as dry sample to mortuary

Send to the mortuary department, QEUH*

Retained products of conception (RPOC) specimen in which there has been a separately identified fetus.

Histopathology required

  • Pathology/tissue specimen in formalin
  • Pathology request to confirm RPOC
  • No need for Form 2 for RPOC component

Send to Pathology Department QEUH*

Retained products of conception (RPOC) specimen with NO separately identified fetus

Histopathology required

  • Pathology/tissue specimen in formalin
  • Pathology request to confirm RPOC
  • Completed Form 2

Send to Pathology department QEUH*

*if parents want to take tissue home from mortuary following cytogenetics and histopathology, they will require to have a Form PATH-COM-COMF-006 completed at the time of collection from pathology. This form makes them aware of the risks of handling tissue that has been stored in formalin. Pathology staff will complete the form with the family collecting the tissue. Photographic Identification is required for collection of tissue. Please make the family aware that there may not be any tissue remaining after examination.

Editorial Information

Last reviewed: 14/06/2022

Next review date: 14/07/2025

Author(s): Dr Felicity Watson, Claire Higgins.

Version: 3

Approved By: Gynaecology Clinical Governance Group

Document Id: 340